Cost-Effectiveness in Adult Spinal Deformity Surgery
- 16 March 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 83 (4) , 597-601
Abstract
The complexity and heterogeneity of adult spinal deformity (ASD) creates significant difficulties in performing high-quality, complete economic analyses. For the same reasons, however, such studies are immensely valuable to clinicians and health policy experts. There has been a paradigm shift towards value-based healthcare provision and as such, there is an increasing focus on demonstrating not just the value ASD surgery, but the provision of care at large. Health-related quality of life measures are an important tool for assessing value of an intervention and its effect on a quality-adjusted life year (QALY). Currently, there are no definitive criteria in regard to assigning the appropriate value to a QALY. A general accepted threshold discussed in literature is $100 000 per QALY gained. However, this figure may be variable across populations, and may not necessarily be applicable in today's economy, or in all healthcare economies. Fundamentally, an effective treatment method may be associated with a high upfront cost, however, if durable, will be cost-effective over time. The emphasis on cost-effectiveness and cost-utility analysis in the field of adult spine deformity is relatively recent; therefore, there is a limited amount of data on cost-effectiveness analyses. Continued efforts with emphasis on value-based outcomes are needed with long-term follow-up studies.Keywords
This publication has 25 references indexed in Scilit:
- Total hospital costs of surgical treatment for adult spinal deformity: an extended follow-up studyThe Spine Journal, 2014
- Analysis of the direct cost of surgery for four diagnostic categories of adult spinal deformityThe Spine Journal, 2013
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Comparative Effectiveness Evidence From the Spine Patient Outcomes Research TrialSpine, 2011
- Risk-Benefit Assessment of Surgery for Adult ScoliosisSpine, 2011
- The Costs and Benefits of Nonoperative Management for Adult ScoliosisSpine, 2010
- Defining Value in Spine CareAmerican Journal of Medical Quality, 2009
- Does Treatment (Nonoperative and Operative) Improve the Two-Year Quality of Life in Patients With Adult Symptomatic Lumbar ScoliosisSpine, 2009
- Operative Versus Nonoperative Treatment of Leg Pain in Adults With ScoliosisSpine, 2009
- The death of cost‐minimization analysis?Health Economics, 2001